UBS AG - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 93 filers reported holding ENZO BIOCHEM INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AG ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2014$193,000
-15.0%
37,366
-13.3%
0.00%
Q2 2014$227,000
+66.9%
43,110
+31.6%
0.00%
Q1 2014$136,000
+142.9%
32,754
+72.3%
0.00%
Q4 2013$56,000
+80.6%
19,010
+52.0%
0.00%
Q3 2013$31,000
+3.3%
12,510
-13.3%
0.00%
Q2 2013$30,00014,4270.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders